The role of the microbiota in the management of intensive care patients
Abstract The composition of the gut microbiota is highly dynamic and changes according to various conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence knowledge about its composition has significantly arisen from culture-independent methods based on next-ge...
| Published in: | Annals of Intensive Care |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13613-021-00976-5 |
| _version_ | 1875913193258221568 |
|---|---|
| author | Piotr Szychowiak Khanh Villageois-Tran Juliette Patrier Jean-François Timsit Étienne Ruppé |
| author_facet | Piotr Szychowiak Khanh Villageois-Tran Juliette Patrier Jean-François Timsit Étienne Ruppé |
| author_sort | Piotr Szychowiak |
| collection | DOAJ |
| container_title | Annals of Intensive Care |
| description | Abstract The composition of the gut microbiota is highly dynamic and changes according to various conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence knowledge about its composition has significantly arisen from culture-independent methods based on next-generation sequencing (NGS) such as 16S profiling and shotgun metagenomics. The gut microbiota of patients hospitalized in intensive care units (ICU) undergoes many alterations because of critical illness, antibiotics, and other ICU-specific medications. It is then characterized by lower richness and diversity, and dominated by opportunistic pathogens such as Clostridioides difficile and multidrug-resistant bacteria. These alterations are associated with an increased risk of infectious complications or death. Specifically, at the time of writing, it appears possible to identify distinct microbiota patterns associated with severity or infectivity in COVID-19 patients, paving the way for the potential use of dysbiosis markers to predict patient outcomes. Correcting the microbiota disturbances to avoid their consequences is now possible. Fecal microbiota transplantation is recommended in recurrent C. difficile infections and microbiota-protecting treatments such as antibiotic inactivators are currently being developed. The growing interest in the microbiota and microbiota-associated therapies suggests that the control of the dysbiosis could be a key factor in the management of critically ill patients. The present narrative review aims to provide a synthetic overview of microbiota, from healthy individuals to critically ill patients. After an introduction to the different techniques used for studying the microbiota, we review the determinants involved in the alteration of the microbiota in ICU patients and the latter’s consequences. Last, we assess the means to prevent or correct microbiota alteration. |
| format | Article |
| id | doaj-art-e1d71a7cd44a4dac83ff1bc4fd30201f |
| institution | Directory of Open Access Journals |
| issn | 2110-5820 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Elsevier |
| record_format | Article |
| spelling | doaj-art-e1d71a7cd44a4dac83ff1bc4fd30201f2026-04-03T02:09:54ZengElsevierAnnals of Intensive Care2110-58202022-01-0112111610.1186/s13613-021-00976-5The role of the microbiota in the management of intensive care patientsPiotr Szychowiak0Khanh Villageois-Tran1Juliette Patrier2Jean-François Timsit3Étienne Ruppé4Université de Paris, IAME, INSERMUniversité de Paris, IAME, INSERMUniversité de Paris, IAME, INSERMUniversité de Paris, IAME, INSERMUniversité de Paris, IAME, INSERMAbstract The composition of the gut microbiota is highly dynamic and changes according to various conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence knowledge about its composition has significantly arisen from culture-independent methods based on next-generation sequencing (NGS) such as 16S profiling and shotgun metagenomics. The gut microbiota of patients hospitalized in intensive care units (ICU) undergoes many alterations because of critical illness, antibiotics, and other ICU-specific medications. It is then characterized by lower richness and diversity, and dominated by opportunistic pathogens such as Clostridioides difficile and multidrug-resistant bacteria. These alterations are associated with an increased risk of infectious complications or death. Specifically, at the time of writing, it appears possible to identify distinct microbiota patterns associated with severity or infectivity in COVID-19 patients, paving the way for the potential use of dysbiosis markers to predict patient outcomes. Correcting the microbiota disturbances to avoid their consequences is now possible. Fecal microbiota transplantation is recommended in recurrent C. difficile infections and microbiota-protecting treatments such as antibiotic inactivators are currently being developed. The growing interest in the microbiota and microbiota-associated therapies suggests that the control of the dysbiosis could be a key factor in the management of critically ill patients. The present narrative review aims to provide a synthetic overview of microbiota, from healthy individuals to critically ill patients. After an introduction to the different techniques used for studying the microbiota, we review the determinants involved in the alteration of the microbiota in ICU patients and the latter’s consequences. Last, we assess the means to prevent or correct microbiota alteration.https://doi.org/10.1186/s13613-021-00976-5MicrobiotaDysbiosisFecal microbiota transplantationProbioticsIntensive careC. difficile |
| spellingShingle | Piotr Szychowiak Khanh Villageois-Tran Juliette Patrier Jean-François Timsit Étienne Ruppé The role of the microbiota in the management of intensive care patients Microbiota Dysbiosis Fecal microbiota transplantation Probiotics Intensive care C. difficile |
| title | The role of the microbiota in the management of intensive care patients |
| title_full | The role of the microbiota in the management of intensive care patients |
| title_fullStr | The role of the microbiota in the management of intensive care patients |
| title_full_unstemmed | The role of the microbiota in the management of intensive care patients |
| title_short | The role of the microbiota in the management of intensive care patients |
| title_sort | role of the microbiota in the management of intensive care patients |
| topic | Microbiota Dysbiosis Fecal microbiota transplantation Probiotics Intensive care C. difficile |
| url | https://doi.org/10.1186/s13613-021-00976-5 |
| work_keys_str_mv | AT piotrszychowiak theroleofthemicrobiotainthemanagementofintensivecarepatients AT khanhvillageoistran theroleofthemicrobiotainthemanagementofintensivecarepatients AT juliettepatrier theroleofthemicrobiotainthemanagementofintensivecarepatients AT jeanfrancoistimsit theroleofthemicrobiotainthemanagementofintensivecarepatients AT etienneruppe theroleofthemicrobiotainthemanagementofintensivecarepatients AT piotrszychowiak roleofthemicrobiotainthemanagementofintensivecarepatients AT khanhvillageoistran roleofthemicrobiotainthemanagementofintensivecarepatients AT juliettepatrier roleofthemicrobiotainthemanagementofintensivecarepatients AT jeanfrancoistimsit roleofthemicrobiotainthemanagementofintensivecarepatients AT etienneruppe roleofthemicrobiotainthemanagementofintensivecarepatients |
